Changchun Bcht Biotechnology Co.

This early-stage study tests an mRNA vaccine designed to prevent genital herpes caused by HSV-2. About 144 healthy adults aged 18-55 will receive different doses to check safety and immune response. The vaccine aims to train the body to fight the virus, potentially stopping infec…

This study looks at how the nasal spray flu vaccine works in children and teens aged 3 to 17. Researchers will measure special antibodies in the nose to see how the body fights the flu. The goal is to understand the immune response better and improve future vaccines.

This early-stage study is testing whether a new freeze-dried rabies vaccine is safe for people aged 10 to 60. Eighty healthy volunteers will receive the vaccine and be monitored for side effects for 30 days. The goal is to prevent rabies, not to treat it after exposure.

This study tests a new version of the rabies vaccine to see if different timing of shots works as well as the standard schedule. About 3,000 healthy people aged 10 to 60 will take part. Researchers will measure how many people develop protective antibodies and check for side effe…